Cancer Immunotherapy Guidelines – Lung Cancer

The Cancer Immunotherapy Guidelines-Lung Cancer Task Force is currently developing a consensus statement specific to lung cancer.

Lung Cancer Steering Committee & Task Force

Julie Brahmer, MD - Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Ramaswamy Govindan, MD - Washington University School of Medicine
Naiyer Rizvi, MD - Columbia University Medical Center

Robert A. Anders, MD, PhD Johns Hopkins University School of Medicine	Scott J. Antonia, MD, PhD Moffitt Cancer Center
Sarah Bonerigo, PA Johns Hopkins University School of Medicine	Marianne Davies, NP Yale Cancer Center
Steven M. Dubinett, MD David Geffen School of Medicine at UCLA	Andrea Ferris LUNGevity
Leena Gandhi, MD, PhD Dana-Farber Cancer Institute	Edward Garon, MD David Geffen School of Medicine at UCLA
Matthew D. Hellmann, MD Memorial Sloan Kettering Cancer Center	Fred R. Hirsch, MD, PhD University of Colorado School of Medicine
Shakuntala Malik, MD National Cancer Institute, National Institutes of Health	Joel Neal, MD, PhD Stanford School of Medicine
Vassiliki Papadimitrakopoulou, MD The University of Texas MD Anderson Cancer Center	David L Rimm, MD, PhD Yale University School of Medicine
Lawrence H. Schwartz MD Columbia University College of Physicians and Surgeons	Boris Sepesi, MD, FACS The University of Texas MD Anderson Cancer Center
Beow Yong Yeap, ScD Massachusetts General Hospital, Harvard Medical School